MR. ANDREW ALEX SELZMAN M.D NPI 1407855356

NPI Details

MR. Andrew Alex Selzman, M.D is an urology in Houston, TX with 37 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. MR. Andrew Alex Selzman, M.D NPI is 1407855356. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS MEDICAL SCHOOL AT SAN ANTONIO
Graduation Year:1989

The provider's business location address is:

915 GESSNER RD
SUITE 720
HOUSTON, TX
ZIP 77024-527
Phone: (713) 830-9100
Fax: (713) 830-9181

The NPI 1407855356 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Automated urinalysis test (HCPCS:81003)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Limited ultrasound scan behind abdominal cavity (HCPCS:76775)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Injection, tobramycin sulfate, up to 80 mg (HCPCS:J3260)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection, garamycin, gentamicin, up to 80 mg (HCPCS:J1580)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Biopsy of prostate gland (HCPCS:55700)
• Simple insertion of temporary bladder tube (HCPCS:51702)
• Biopsy of bladder using an endoscope (HCPCS:52204)
• Imaging of urinary tract following injection of a contrast agent (HCPCS:74420)
• Ultrasonic guidance for administration of radiation therapy (HCPCS:76965)
• Insertion of needle or tube into prostate for radiation therapy (HCPCS:55875)
• Shock wave crushing of kidney stones (HCPCS:50590)
• Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope (HCPCS:52310)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope (HCPCS:52601)
• Dilation of urethra using an endoscope (HCPCS:52281)
• Insertion of temporary bladder tube (HCPCS:51701)
• Prostate resection (HCPCS:NAN14)

The enumeration date for this NPI number is 7/21/2005 and was last updated on 3/30/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.